The Anti-rheumatics market size is USD 69.7 Billion in 2026.
The Anti-rheumatics market is projected to grow at a 2.0% CAGR by 2033.
The Anti-rheumatics market growth drivers include advancements in biologic therapies, increasing prevalence of rheumatic diseases, and focus on early diagnosis and intervention.
North America is the dominant region for the Anti-rheumatics market.
AbbVie, Pfizer, Johnson & Johnson, Bristol Myers Squibb, and Novartis are some leading industry players in the Anti-rheumatics market.